Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Gynecologic 4 Genitourinary 4 Plasma cell 2 Other hematologic neoplasm 2 Breast 2 Thoracic 1 NET 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 111 Gastro-enteropancreatic neuroendocrine tumor 19 Carcinoma, Neuroendocrine 12 Stomach Neoplasms 11 Pancreatic Neoplasms 10 Neoplasms 10 Breast Neoplasms 10 Pheochromocytoma 9 Carcinoid Tumor 9 Prostatic Neoplasms 8 Paraganglioma 8 Neoplasm Metastasis 8 Carcinoma, Hepatocellular 8 Adenoma, Islet Cell 8 Thyroid Neoplasms 7 Sarcoma 7 Gastrointestinal Neoplasms 7 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Lung Neoplasms 6 Rectal Neoplasms 5 Ovarian Neoplasms 5 Neuroblastoma 5 Melanoma 5 Liver Neoplasms 5 Colonic Neoplasms 5 Anus Neoplasms 5 Uterine Cervical Neoplasms 4 Gastrointestinal Stromal Tumors 4 Cholangiocarcinoma 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Frailty × NET × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡